Cita APA

Zhao, X., Suryawanshi, S., Hruska, M., Feng, Y., Wang, X., Shen, J., . . . Agrawal, S. (2017). Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors. Ann Oncol.

Citación estilo Chicago

Zhao, X., et al. "Assessment of Nivolumab Benefit–risk Profile of a 240-mg Flat Dose Relative to a 3-mg/kg Dosing Regimen in Patients With Advanced Tumors." Ann Oncol 2017.

Cita MLA

Zhao, X., et al. "Assessment of Nivolumab Benefit–risk Profile of a 240-mg Flat Dose Relative to a 3-mg/kg Dosing Regimen in Patients With Advanced Tumors." Ann Oncol 2017.